Optimizing mycobacterial culture in smear-negative, human immunodeficiency virus-infected Tuberculosis cases

dc.contributor.authorIsmail, Nazir Ahmed
dc.contributor.authorSaid, H.M. (Halima Mohammed)
dc.contributor.authorPinini, Z.
dc.contributor.authorOmar, Shaheed Vally
dc.contributor.authorBeyers, N.
dc.contributor.authorNaidoo, P.
dc.date.accessioned2016-03-08T10:21:35Z
dc.date.available2016-03-08T10:21:35Z
dc.date.issued2015-11-06
dc.description.abstractINTRODUCTION Tuberculosis (TB) is a significant public health problem and the diagnosis in human immunodeficiency virus (HIV)—infected individuals is challenging. The use of mycobacterial culture remains an important complementary tool and optimizing it has important benefits. We sought to determine the effect of an increase in the number of specimens evaluated, addition of nutritional supplementation to the culture medium, sputum appearance and volume on diagnostic yield and time to detection of pulmonary TB among smear-negative, HIVinfected adults. METHODS In this prospective study conducted at the Tshwane District Hospital and Academic TB Laboratory, Pretoria, South Africa we collected three sputum specimens an hour apart from presumptive TB cases at an antiretroviral treatment site. We analysed specimens from 236 patients. Specimen appearance and volume were recorded. All specimens were processed for culture using both standard and supplemented media. RESULTS A single specimen identified 79% of PTB cases using standard media; the second and third specimens added 12.5% and 8.3% respectively. Media supplementation, sputum appearance and specimen volume had no effect on culture yield or contamination rates. The mean time to detection was reduced from 19.8 days in standard cultures to 11.8 days in nutrient supplemented cultures (p = 0.002). For every 1 ml increase in sputum volume, time to detection was decreased by a factor of 0.797 (p = 0.011). CONCLUSION Use of an inexpensive culture supplement substantially reduced time to detection and could contribute to reducing treatment delay among HIV-infected cases.en_ZA
dc.description.librarianam2015en_ZA
dc.description.sponsorshipA United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB – Agreement No. GHN-A-00-08-00004-00).en_ZA
dc.description.urihttp://www.plosone.orgen_ZA
dc.identifier.citationIsmail NA, Said HM, Pinini Z, Omar SV, Beyers N, Naidoo P (2015) Optimizing Mycobacterial Culture in Smear-Negative, Human Immunodeficiency Virus-Infected Tuberculosis Cases. PLoS ONE 10(11): e0141851. DOI: 10.1371/journal.pone.0141851.en_ZA
dc.identifier.issn1932-6203
dc.identifier.other10.1371/journal.pone.0141851
dc.identifier.urihttp://hdl.handle.net/2263/51718
dc.language.isoenen_ZA
dc.publisherPublic Library of Scienceen_ZA
dc.rights© 2015 Ismail et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.en_ZA
dc.subjectAdultsen_ZA
dc.subjectTuberculosis (TB)en_ZA
dc.subjectHuman immunodeficiency virus (HIV)en_ZA
dc.subjectMycobacterial cultureen_ZA
dc.titleOptimizing mycobacterial culture in smear-negative, human immunodeficiency virus-infected Tuberculosis casesen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Ismail_Optimizing_2015.PDF
Size:
348.38 KB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Ismail_OptimizingAddFile1_2015.xls
Size:
142.5 KB
Format:
Microsoft Excel
Description:
Additional file 1

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: